131. Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study
Khaled Naja1, Najeha Anwardeen1, Sara S. Bashraheel and Mohamed A. Elrayess
17 September 2024
129. Genome-wide association study and polygenic score assessment of insulin resistance
Usama Aliyu1, Umm-Kulthum Ismail Umlai1, Salman M. Toor1, Asma A. Elashi1, Yasser A. Al-Sarraj2, Abdul Badi Abou−Samra3,Karsten Suhre4,5 and Omar M. E. Albagha1
13 June 2024
130. A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes
Anna Halama , Shaza Zaghlool, Gaurav Thareja, Sara Kader, Wadha Al Muftah, Marjonneke Mook-Kanamori, Hina Sarwath, Yasmin Ali Mohamoud, Nisha Stephan1,, Sabine Ameling,
Maja Pucic Baković, Jan Krumsiek, Cornelia Prehn, Jerzy Adamski , Jochen M. Schwenk, Nele Friedrich, Uwe Völker, ManfredWuhrer, Gordan Lauc. S. Hani Najafi-Shoushtari1, Joel A. Malek, Johannes Graumann, Dennis Mook-Kanamori, Frank Schmidt & Karsten Suhre
19 August 2024
128. Genome-wide association study and trans-ethnic meta-analysis identify novel susceptibility loci for type 2 diabetes mellitus
Asma A Elashi1, Salman M Toor1, Umm-Kulthum Ismail Umlai1, Yasser A Al-Sarraj, Shahrad Taheri, Karsten Suhre, Abdul Badi Abou-Samra and Omar M E Albagha1.
29 April 2024
Qatar Precision Health Institute Advances Precision Health Through Transformative Workshop
6 min read
December 02,2024
Transforming Healthcare: Qatar Precision Health Institute's Innovative Approach to Precision Medicine Highlighted in Documentary Series by Reuters
6 min read
November 03,2024
QPHI Advances Precision Health with Release of 25,000 New Genomic Data and New Opportunities for Research Collaborations
6 min read
October 24,2024
Qatar Foundation-Led Study Reveals Vital Genetic Findings for Advancing Personalized Healthcare
6 min read
July 24,2024
Qatar Precision Health Institute embarks on collaboration journey to translate research into tangible, front-line healthcare
6 min read
May 06,2024
